Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
28.14
-0.19 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
28.35
+0.21 (0.75%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Royalty Pharma Employees
Royalty Pharma had 89 employees as of December 31, 2023. The number of employees increased by 14 or 18.67% compared to the previous year.
Employees
89
Change (1Y)
14
Growth (1Y)
18.67%
Revenue / Employee
$25,152,371
Profits / Employee
$8,975,921
Market Cap
12.72B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89 | 14 | 18.67% |
Dec 31, 2022 | 75 | 9 | 13.64% |
Dec 31, 2021 | 66 | 15 | 29.41% |
Dec 31, 2020 | 51 | 16 | 45.71% |
Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Tenet Healthcare | 106,500 |
DaVita | 70,000 |
Dr. Reddy's Laboratories | 27,048 |
Smith & Nephew | 19,081 |
Revvity | 11,500 |
Medpace Holdings | 5,900 |
Natera | 3,293 |
RPRX News
- 2 days ago - Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 - GlobeNewsWire
- 4 days ago - Royalty Pharma Declares Third Quarter 2024 Dividend - GlobeNewsWire
- 5 weeks ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 6 weeks ago - Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes - GlobeNewsWire
- 7 weeks ago - Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million - GlobeNewsWire
- 2 months ago - Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline - GlobeNewsWire
- 2 months ago - Royalty Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire